l carnitine syrup L-Carnitine Carnitol 30 % Syrup (
Description
[PubMed: 26621156] 97
Early symptoms may be subtle and non-specific, making diagnosis challenging
Product quality varies dramatically in the peptide market
For injectable use in musculoskeletal indicationsthe relevant route for the KLOW stackevidence is almost entirely preclinical
Encephale 14:339-344, 1988
[DOI] [PubMed] [Google Scholar] 192.Valentino MA, Lin JE, Waldman SA
